Latest Alan James Group Stories
PARK CITY, Utah, Nov. 20, 2012 /PRNewswire/ -- Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2012 fourth quarter ended September 30, 2012. Net sales for the fiscal 2012 fourth quarter were $50.3 million compared to $45.8 million for the same quarter of fiscal 2011. For the fourth quarter of fiscal 2012, net income was $4.2 million, or $0.42 diluted earnings per share, compared to net income of $3.3 million, or $0.32 diluted earnings...
PARK CITY, Utah, July 26, 2012 /PRNewswire/ -- Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2012 third quarter ended June 30, 2012. Net sales for the fiscal 2012 third quarter were $49.6 million compared to $47.5 million for the same quarter of fiscal 2011. For the third quarter of fiscal 2012, net income was $3.4 million, or $0.34 diluted earnings per share, compared to net income of $3.9 million, or $0.38 diluted earnings per...
WALTHAM, Mass., Aug. 13 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) today announced financial and operational results for the second quarter ended June 30, 2009. "The launch of our new Inherent Health brand of genetic test products marked a significant milestone for the Company in the second quarter. Our novel and unique product, the Weight Management genetic test, has been well received and is generating interest through a number of channels," said Lewis H....
WALTHAM, Mass., July 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today that on June 30, 2009 it executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands, Inc. to Pep Products, Inc., a subsidiary of Nutraceutical Corporation, for approximately $4.6 million in cash. The transaction was completed following the close of business on June 30th. "While the Alan James Group business saw an increase in sales during the last...
BOCA RATON, Fla., Aug. 21 /PRNewswire-FirstCall/ -- Alan James Group (AJG), a wholly owned subsidiary of Interleukin Genetics, Inc. , announced today that it has launched several new websites for its line of branded nutritional supplements, including Ginsana(R), Ginkoba(R), Venastat(R), Optiform SAM-e(R), Cransana(R) and Ginsana Gold Multiplex(R). AJG markets items in multiple categories in the Food, Drug and Mass (FD&M) channels, including Energy, Memory, Leg Vein Health and Heart Health....
